menu
    • menu

    Company profile for ImPact Biotech

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy, a targeted treatment for selective tumor ablation. The company is headquartered in Israel, with a presence in Luxembourg, France, and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel. ImPact Biotech holds exclusive rights from the Weizmann Institute of S...
    ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy, a targeted treatment for selective tumor ablation. The company is headquartered in Israel, with a presence in Luxembourg, France, and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel. ImPact Biotech holds exclusive rights from the Weizmann Institute of Science (WIS, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York), to develop and commercialize drugs and related technologies used in VTP.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImPact BiotechIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    16 Einstein St., Kiryat Weizmann Science Park, PO Box 4052, 7403620 Ness Ziona...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://impactbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/stebabiotech-s-a/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Impact Bio Unveils Phase 3 Padeliporfin VTP Data In LG UTUC
    Impact Bio Unveils Phase 3 Padeliporfin VTP Data In LG UTUC

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3200305/0/en/ImPact-Biotech-Presents-Updated-Preliminary-Data-from-Phase-3-ENLIGHTED-Study-of-Padeliporfin-VTP-in-LG-UTUC-at-SUO-2025.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Impact Biotech Presents ENLIGHTED Phase 3 Data at SUO 2025
    Impact Biotech Presents ENLIGHTED Phase 3 Data at SUO 2025

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191416/0/en/ImPact-Biotech-to-Present-Updated-Interim-Phase-3-Data-from-ENLIGHTED-Study-of-Padeliporfin-VTP-in-Low-Grade-UTUC-at-SUO-2025.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    ImPact Biotech Treats First Patient in Padeliporfin VTP Trial
    ImPact Biotech Treats First Patient in Padeliporfin VTP Trial

    05 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/05/3094792/0/en/ImPact-Biotech-Announces-Treatment-of-First-Patient-in-Phase-1-Clinical-Trial-of-Padeliporfin-VTP-in-Locally-Advanced-Unresectable-Pancreatic-Ductal-Adenocarcinoma-PDAC.html

    GLOBENEWSWIRE
    05 Jun 2025
    Share Share
    ImPact Shares Ph3 UTUC Data For Padeliporfin At ASCO 2025
    ImPact Shares Ph3 UTUC Data For Padeliporfin At ASCO 2025

    31 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/31/3091402/0/en/ImPact-Biotech-Presents-Interim-Analysis-from-Phase-3-ENLIGHTED-Study-of-Padeliporfin-VTP-in-LG-UTUC-at-ASCO-2025.html

    GLOBENEWSWIRE
    31 May 2025
    Share Share
    ImPact Biotech To Present ENLIGHTED Study At ASCO 2025
    ImPact Biotech To Present ENLIGHTED Study At ASCO 2025

    22 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/22/3087155/0/en/ImPact-Biotech-Announces-Late-Breaking-Podium-Presentation-at-ASCO-2025-Highlighting-ENLIGHTED-Study-Interim-Analysis.html

    GLOBENEWSWIRE
    22 May 2025
    Share Share
    ImPact Biotech Presents Updated Padeliporfin VTP Data at AUA 2025
    ImPact Biotech Presents Updated Padeliporfin VTP Data at AUA 2025

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069134/0/en/ImPact-Biotech-Presents-Updated-Efficacy-Data-from-Evaluation-of-Padeliporfin-VTP-in-LG-UTUC-and-Intermediate-Risk-Prostate-Cancer-at-AUA-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search